SURFACTANT THERAPY IMPROVES PULMONARY-FUNCTION IN INFANTS WITH PNEUMOCYSTIS-CARINII PNEUMONIA AND ACQUIRED-IMMUNODEFICIENCY-SYNDROME

Authors
CREERY WD HASHMI A HUTCHISON JS SINGH RN
Citation
Wd. Creery et al., SURFACTANT THERAPY IMPROVES PULMONARY-FUNCTION IN INFANTS WITH PNEUMOCYSTIS-CARINII PNEUMONIA AND ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Pediatric pulmonology, 24(5), 1997, pp. 370-373
Citations number
12
Journal title
Pediatric pulmonology → ACNP
ISSN journal
87556863
Volume
24
Issue
5
Year of publication
1997
Pages
370 - 373
Database
ISI
SICI code
8755-6863(1997)24:5<370:STIPII>2.0.ZU;2-#
Abstract
Pneumocystis carinii pneumonia (PCP) is an important cause of acute re spiratory failure in HIV-infected children. PCP may initiate acute res piratory distress syndrome (ARDS) by adversely affecting surfactant ph ysiology. We report improved pulmonary function following administrati on of bovine lipid extract surfactant to two infants with AIDS-related PCP/ARDS. (C) 1997 Wiley-Liss, Inc.